FNIRS-based exploration of the central mechanism of transcutaneous sacral nerve magnetic stimulation for constipation in patients with Parkinson's disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300074628

Enrollment

Unknown

Registered

2023-08-11

Start date

2023-08-01

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Test group:transcutaneous sacral nerve magnetic stimulation treatment

control group:transcutaneous sacral nerve magnetic stimulation treatment(false stimulation)

Eligibility

Sex/Gender

All

Age

20 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Age 20-75 years, regardless of gender; ? meet the diagnostic criteria for clinically confirmed or likely Parkinson's disease established by the International Games Disorders Association in 2015; ? meet the Rome IV diagnostic criteria for functional constipation; ? having some cognitive ability with MMSE = 20; ? Signed informed consent for treatment;

Exclusion criteria

Exclusion criteria: ? Pregnant or lactating women; ? Severe cognitive impairment; ? Metal placement near the site of irritation; ? constipation caused by the bowel itself and systemic organic disease itself; ? Concomitant severe underlying disease; ? Already involved in other clinical programs;

Design outcomes

Primary

Measure	Time frame
Oxygenation, deoxygenation, total haemoglobin;	—

Secondary

Measure	Time frame
WEXNER Constipation Severity Score;Anal canal resting pressure, anal canal maximal voluntary systolic pressure;	—

Countries

China

Contacts

Public ContactKaili Wang

The First Affiliated Hospital of Xi'an Jiaotong University

18292041726@163.com+86 182 9204 1726

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026